Intense vigilance and early intervention are important, since age of diagnosis is low, especially among CDKN2A mutants, while medical advice on healthy lifestyle and prompt screening for other cancers, such as pancreatic cancer, is essential. This evidence concerns the gene CDKN2A and pancreatic neoplasm.